Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1992-10-16
pubmed:abstractText
Epstein-Barr virus (EBV)-specific DNA sequences were detected by polymerase chain reaction analysis in 15 of 47 (32%) DNA extracts prepared from CD30-positive (Ki-1 antigen-positive) anaplastic large cell (ALC) lymphomas. EBV-encoded RNA (EBER) transcripts could be detected by in situ hybridization in the tumor cells of 9 of 11 EBV DNA-positive cases. Twenty-eight cases were examined by immunohistology on cryostat sections for the presence of the EBV-encoded latent membrane protein (LMP), the nuclear antigen 2 (EBNA2), the BZLF1 transactivator protein, and the late viral glycoprotein gp350/250. A distinct LMP-specific membrane and cytoplasmic staining was detected exclusively in lymphoma cells of five cases (18%); two of these cases additionally expressed EBNA2. BZLF1 protein and gp350/250 immunoreactivity was absent in all instances. All LMP-positive cases contained EBV DNA and EBER sequences. The pattern of EBV latent protein expression in ALC lymphomas showed heterogeneity with respect to EBNA2 expression: LMP-positive/EBNA2-negative cases displayed a pattern previously described for undifferentiated nasopharyngeal carcinomas and Hodgkin's disease, whereas LMP-positive and EBNA2-positive cases showed parallels to lymphoblastoid cell lines. Because the LMP gene has transforming potential, our findings support the concept of a pathoetiologic role for EBV in a proportion of CD30-positive ALC lymphomas.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2666-73
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:1668608-Adult, pubmed-meshheading:1668608-Aged, pubmed-meshheading:1668608-Antigens, CD, pubmed-meshheading:1668608-Antigens, CD30, pubmed-meshheading:1668608-Antigens, Neoplasm, pubmed-meshheading:1668608-Antigens, Viral, pubmed-meshheading:1668608-Base Sequence, pubmed-meshheading:1668608-DNA, Viral, pubmed-meshheading:1668608-DNA-Binding Proteins, pubmed-meshheading:1668608-Epstein-Barr Virus Nuclear Antigens, pubmed-meshheading:1668608-Female, pubmed-meshheading:1668608-Genes, Viral, pubmed-meshheading:1668608-Genome, Viral, pubmed-meshheading:1668608-Herpesvirus 4, Human, pubmed-meshheading:1668608-Humans, pubmed-meshheading:1668608-Immunophenotyping, pubmed-meshheading:1668608-Lymph Nodes, pubmed-meshheading:1668608-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:1668608-Male, pubmed-meshheading:1668608-Middle Aged, pubmed-meshheading:1668608-Molecular Sequence Data, pubmed-meshheading:1668608-Oligodeoxyribonucleotides, pubmed-meshheading:1668608-Polymerase Chain Reaction, pubmed-meshheading:1668608-Restriction Mapping
pubmed:year
1991
pubmed:articleTitle
Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas.
pubmed:affiliation
Institute of Pathology, Klinikum Steglitz, Free University of Berlin, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't